ライフサイエンスコーパス: hip fracture

1 ival was reduced by 17% (hip fracture vs. no hip fracture).

2 perienced a first fracture at any site (3871 hip fractures).

3 ignificantly increased risk for both MOF and hip fracture.

4 CT for suspicion of a nondisplaced traumatic hip fracture.

5 5% CI, 0.45-0.99, P = .05) for patients with hip fracture.

6 The primary outcome was incident hip fracture.

7 ge, and 1, 3, 6, 12, 18, 24 months following hip fracture.

8 ars at baseline in 1994-2003) with regard to hip fracture.

9 I; weight (kg)/height (m)(2)) lowers risk of hip fracture.

10 .4 years, 1,603 women and 951 men suffered a hip fracture.

11 c fracture, and of these, 129 (10.9%) were a hip fracture.

12 o associations between gabapentinoid use and hip fracture.

13 shows a weakly positive protective trend for hip fracture.

14 completed traditional rehabilitation after a hip fracture.

15 -term functional limitations persist after a hip fracture.

16 ienced fracture of any type, and 3,871 had a hip fracture.

17 rs of follow-up, 95 men (1.7%) experienced a hip fracture.

18 quality indicators, and hospitalization for hip fracture.

19 l health of older adults after discharge for hip fracture.

20 Index (CCI) score, was observed 1 year after hip fracture.

21 d to extract parameters best associated with hip fracture.

22 ) versus 2.4 (95% CI: 1.5, 3.7) for incident hip fracture.

23 ndisplaced hip fractures and 96 did not have hip fractures.

24 atic major osteoporotic fractures (MOFs) and hip fractures.

25 loped incident fractures, including 198 with hip fractures.

26 radiography have a high frequency of occult hip fractures.

27 he relation of soda consumption with risk of hip fractures.

28 y of follow-up, we identified 1873 incident hip fractures.

29 whether these effects are driven largely by hip fractures.

30 MAIN OUTCOME MEASURES: One-year incidence of hip fractures.

31 ned similar in analyses limited to spine and hip fractures.

32 s (mean age, 80.2 years +/- 11.0) with acute hip fractures.

33 feasible, and could be effective in reducing hip fractures.

34 ), hazard ratio (HR) 0.46, 95% CI 0.40-0.53; hip fractures 0.8% (65/8043) versus 1.6% (125/8028), 0.5

35 183), but screening reduced the incidence of hip fractures (0.72, 0.59-0.89, p=0.002).

36 teoporotic fractures: 0.90 (0.83, 0.96); for hip fractures: 0.85 (0.81, 0.89) per z score of dietary

37 9.6% (675/7011), HR 0.48, 95% CI 0.42-0.55; hip fractures 1.1% (86/8043) versus 2.0% (162/8028), 0.5

38 5 +/- 5.25 vs. 5.50 +/- 5.52; P < 0.001) and hip fractures (1.57 +/- 2.40 vs. 1.79 +/- 2.69; P = 0.00

39 F, 1.15; 95% CI, 1.04-1.26; P < .05; aHR for hip fracture, 1.24; 95% CI, 1.05-1.47; P < .05) were eac

40 F, 1.43; 95% CI, 1.27-1.60; P < .05; aHR for hip fracture, 1.48; 95% CI, 1.18-1.85; P < .05), antipsy

41 teoporotic fractures: 1.08 (1.00, 1.06); for hip fractures: 1.06 (1.02, 1.12) per z score].

42 s (27 per 1000 individuals) were lost due to hip fractures, 1230 (20.6%) of which were in the group a

43 Defining events included 137 hip fractures, 186 myocardial infarctions, 335 incidence

44 raining: 6 [5.7%], control: 4 [3.8%]), femur/hip fracture (2 in each group), pneumonia (training: 2,

45 F, 1.43; 95% CI, 1.15-1.77; P < .05; aHR for hip fracture, 2.14; 95% CI, 1.52-3.02; P < .05), and ben

46 For hip fractures, 2-year AUC for muscle attenuation alone w

47 There were 7.48 hip fracture, 8.18 vertebral fracture, 1.14 AFF, 0.21 es

48 Among older adults with a hip fracture, a multicomponent home-based physical thera

49 tive risk [RR], 0.91; 95% CI, 0.86-0.96) and hip fractures (absolute risk, 0.8 vs 1.0 per 100 person-

50 e the association between BMI and subsequent hip fracture according to sex and age and 2) to explore

51 ed in women identified to be at high risk of hip fracture, according to the FRAX 10-year hip fracture

52 ent subgroups that experienced lower odds of hip fracture after cataract surgery included patients wi

53 andomly assigned home-dwelling patients with hip-fractures aged 70 years or older who were able to wa

54 [aHR], 1.39; 95% CI, 1.27-1.51; P < .05) and hip fracture (aHR, 1.43; 95% CI, 1.22-1.69; P < .05) bef

55 ) and falls, 10-year cumulative incidence of hip fracture alone, and nonvertebral fracture incidence

56 (95% confidence interval (CI): 1.3, 1.7) for hip fracture and 1.4 (95% CI: 1.2, 1.6) for other fall-r

57 95% confidence interval [CI], 1.43-2.48) for hip fracture and 1.52 (95% CI, 1.31-1.75) for nonspine f

58 ars, 76 participants experienced an incident hip fracture and 113 participants experienced a major os

59 Of 1199 men with DM, 32 experienced a hip fracture and 133 a nonspine fracture during a mean (

60 en with DM were 5.71 (95% CI, 3.42-9.53) for hip fracture and 2.17 (95% CI, 1.75-2.69) for nonspine f

61 Of 770 women with DM, 84 experienced a hip fracture and 262 a nonspine fracture during a mean (

62 was somewhat favorable in the prevention of hip fracture and any nonvertebral fracture in persons 65

63 Hazard ratios for hip fracture and associated 95% confidence intervals wer

64 iderably greater after hospitalization for a hip fracture and other fall-related injury than for a no

65 study the association between s-retinol and hip fracture and whether high s-retinol may counteract a

66 ity studies were 1.12 (CI, 0.83 to 1.51) for hip fractures and 1.04 (CI, 0.76 to 1.42) for nonspine f

67 e 7 cohorts were 1.26 (CI, 0.96 to 1.65) for hip fractures and 1.16 (CI, 0.95 to 1.42) for nonspine f

68 yrodism were 1.38 (95% CI, 0.92 to 2.07) for hip fractures and 1.20 (CI, 0.83 to 1.72) for nonspine f

69 rthyroidism were 2.16 (CI, 0.87 to 5.37) for hip fractures and 1.43 (CI, 0.73 to 2.78) for nonspine f

70 age, 76 years; 91% women) with 1111 incident hip fractures and 3770 nonvertebral fractures.

71 Results Twenty-two patients had nondisplaced hip fractures and 96 did not have hip fractures.

72 for the detection of nondisplaced traumatic hip fractures and improved diagnostic confidence in the

73 cium images in the detection of nondisplaced hip fractures and to assess whether obtaining these imag

74 2 hospitalizations for an injurious fall (59 hip-fracture and 63 other fall-related injuries) to 241

75 other conditions leading to hospitalization, hip-fracture and other fall-related injuries are associa

76 For both hip-fracture and other fall-related injuries, the disabi

77 -0.86) for CHF, 0.74 (95% CI, 0.68-0.80) for hip fracture, and 0.78 (95% CI, 0.66-0.91) for colon can

78 MI, 10.2% vs 12.4% for CHF, 7.7% vs 9.7% for hip fracture, and 3.3% vs 3.9% for CHF; fully adjusted r

79 ident MOF, 1579 (2.3%) sustained an incident hip fracture, and 8998 (13.1%) died.

80 lism, colorectal cancer, endometrial cancer, hip fracture, and death.

81 lung cancer, pneumonia, pulmonary embolism, hip fracture, and depression for all participants.

82 and urinary morbidity, erectile dysfunction, hip fractures, and additional cancer therapy.

83 , chronic renal failure, RRT, all fractures, hip fractures, and vertebral fractures occurred in 0.6%,

84 ortions of participants who had at least one hip fracture, any clinical fracture, or mortality; and t

85 onsumption of dairy products and the risk of hip fracture are less well established, although yogurt

86 Globally, hip fractures are among the top 10 causes of disability

87 Hip fractures are associated with a high rate of morbidi

88 Most patients with hip fractures are characterised by older age (>70 years)

89 5% confidence interval (CI): 1.18, 1.60) for hip fracture, as compared with women with BMI 22-24.9; a

90 followed for fracture, the absolute risk for hip fracture at 10 years was 20.4 events per 1000 patien

91 cles are significantly associated with acute hip fracture at CT.

92 ars or older who were undergoing surgery for hip fracture at general acute care hospitals in New York

93 included the incidences of nonvertebral and hip fracture at the time of the primary analysis.

94 rface density (model S1) was associated with hip fracture (AUC, 0.85; 95% confidence interval [CI]: 0

95 with BMD tests and self-reports of parental hip fracture between 2006 and 2014.

96 ho underwent hemiarthroplasty treatment of a hip fracture between 2009 and 2017 at 1 of the 36 hospit

97 the risk factor responsible for the greatest hip fracture burden (7.5%, 95% CI 5.2-9.7) followed by p

98 f patients were clinically suspected to have hip fracture but there was no radiographic evidence of s

99 th less gastrointestinal morbidity and fewer hip fractures but more erectile dysfunction; IMRT compar

100 Nucleotide analogs may increase the risk of hip fracture, but the overall event rate is low.

101 This proof-of-concept study focused on hip fractures, but use of record linkage techniques to v

102 of participants reclassified as high risk of hip fracture by 3.9% (95% CI, -2.2% to 9.9%), whereas it

103 imated the 10-year risk of MOF by 29% and of hip fracture by 51% for those with depression.

104 FRAX underestimated the 10-year risk of hip fracture by 57% for use of selective serotonin reupt

105 Purpose To evaluate determinants of hip fracture by assessing soft-tissue composition of the

106 We computed RRs for hip fractures by the amount of soda consumption by using

107 INTERPRETATION: Hip fracture can lead to a substantial loss of healthy l

108 common, particularly among older women, and hip fractures can be devastating.

109 term analyses, we identified 4912 first-time hip fracture cases and 49,120 controls.

110 stored serum was available in 1154 incident hip fracture cases with valid body mass index (BMI) data

111 e adjusted model (-0.24 hospitalizations for hip fracture [CI, -0.32 to -0.16 hospitalizations] per 1

112 Among women, RRs for low trauma hip fractures compared with nondrinkers were 0.89 (95% C

113 ratio [HR] [95% confidence interval; CI]) of hip fracture, compared to HCV-monoinfected (HR, 1.38; 95

114 ction was associated with increased rates of hip fracture, compared to HCV-monoinfected, HIV-monoinfe

115 ion was associated with an increased risk of hip fracture, compared to uninfected individuals, and th

116 CV infection alone are at increased risk for hip fracture, compared to uninfected individuals, and to

117 noinfected patients had an increased risk of hip fracture, compared to uninfected individuals.

118 amined were other secondary events including hip fractures, congestive heart failure, angina, falls,

119 d whether the combination of comorbidity and hip fracture could explain the previously observed exces

120 Pelvis/hip fractures declined slightly from 29.6 to 20.6 per 10

121 ry incontinence; benefits included decreased hip fractures, diabetes, and vasomotor symptoms.

122 the inclusion criteria; 13.6% had a parental hip fracture diagnosis in administrative data during an

123 onger interval between BMD test and parental hip fracture diagnosis.

124 The association between soda and hip fractures did not differ by body mass index or diagn

125 n with 38,126 Norwegian women who suffered a hip fracture during the period 2009-2015 and the same nu

126 were 13,976 patients (1.3%) who sustained a hip fracture during the study period.

127 Decreases in the risk of osteoporotic and hip fractures during 1 to 10 years of bisphosphonate use

128 , pulmonary embolism, colorectal cancer, and hip fracture) during the intervention phase and 18-year

129 actorial fall-prevention assessment, and one hip fracture) during the trial period.

130 ferent countries show variations of a shared hip fracture epidemic.

131 the US Renal Data System, we identified all hip fracture events recorded among patients dependent on

132 se of opioid analgesics were associated with hip fracture events.

133 d the association between alcohol intake and hip fractures, few have considered specific alcoholic be

134 e relative risks (RRs) of first incidence of hip fracture from low-trauma events per glass (8 fl oz o

135 Agreement between parental hip fracture from offspring reports and diagnoses in adm

136 Results The hip fracture group was characterized by lower BMD, lower

137 Patients undergoing surgery for a hip fracture have a higher risk of mortality and major c

138 per SD decrease was associated with risk of hip fracture (hazard ratio [HR], 1.43 [95% CI, 1.16 to 1

139 .99; 95% confidence interval: 0.98, 1.00) or hip fracture (hazard ratio per 200 mL coffee = 0.97, 95%

140 o 2000), with a 30% reduction in the risk of hip fracture (hazard ratio, 0.70; 95% CI, 0.58 to 0.86)

141 nonsignificant 10% reduction in the risk of hip fracture (hazard ratio, 0.90; 95% confidence interva

142 th nucleoside analogs, increased the risk of hip fracture (HR = 5.69; 95% confidence interval: 1.98-1

143 fracture (HR: 0.66; 95% CI: 0.45, 0.95), and hip fracture (HR: 0.58; 95% CI: 0.36, 0.95).

144 nt use was associated with a reduced rate of hip fracture (HR: 0.78; 95% CI: 0.65, 0.93) and any frac

145 l fracture (HR: 0.99; 95% CI: 0.97, 1.02) or hip fracture (HR: 0.91; 95% CI: 0.84, 1.00), but there w

146 s 1-4) were associated with a higher rate of hip fracture (HR: 3.33; 95% CI: 1.43, 7.76) and any frac

147 intile 4 having significantly lower risks of hip fractures (HR: 0.35; 95% CI: 0.16, 0.80) and spine f

148 enrolled after nonpathologic, minimal trauma hip fracture, if they were living in the community and w

149 -0.86; P = .03), whereas among patients with hip fracture, implementation was associated with increas

150 ndronate was associated with a lower risk of hip fracture in a multivariable-adjusted Cox model (haza

151 the validity of offspring-reported parental hip fracture in a unique bone mineral density (BMD) regi

152 The 10-year cumulative incidence of hip fracture in all recipients was 1.7% (>/=3% defined a

153 ate the frequency of radiographically occult hip fracture in elderly patients, to define the higher-r

154 ride (LPS) in female C57BL/6J mice and acute hip fracture in humans to address whether disrupted ener

155 ociated with a significant 9% higher risk of hip fracture in men (RR = 1.09; 95% CI, 1.01-1.17).

156 The HR for hip fracture in men for each 1-SD decrease in serum alph

157 ears was not associated with a lower risk of hip fracture in older adults.

158 en usual physical activity level and rate of hip fracture in older men or applied semiparametric meth

159 tective effect of usual physical activity on hip fracture in older men.

160 e efficacy of alendronate to protect against hip fracture in older patients using glucocorticoids.

161 Disability persists after hip fracture in older persons.

162 ncluding specific types of soda, and risk of hip fracture in postmenopausal women.

163 pes may be associated with increased risk of hip fracture in postmenopausal women; however, a clear m

164 fication tests, the MSSP was associated with hip fracture in the adjusted model (-0.24 hospitalizatio

165 There was a modest increased risk of hip fracture in the lowest compared with the middle quin

166 rotic fractures in 7.4% (n = 686), including hip fractures in 2.4% (n = 219).

167 rtile range, 0.57-2.34 years), there were 27 hip fractures in the alendronate group and 73 in the no-

168 egy, 12.8% of postmenopausal women sustained hip fractures in their remaining life (no screening, 18.

169 c alcoholic beverage consumption and risk of hip fractures in US men and women.

170 age milk consumption was not associated with hip fractures in women (RR = 1.00 per glass per day; 95%

171 We ascertained 2360 incident low trauma hip fractures in women and 709 in men.

172 th policies should be strengthened to reduce hip fracture incidence and mortality.

173 Compared with 1-year hip fracture incidence in patients with cataract who did

174 ere was no radiographic evidence of surgical hip fracture (including absence of any definite fracture

175 DXA area measure contributes to the risk of hip fracture independent of bone density.

176 An additive comorbidity-hip fracture interaction of 4 or 9 additional deaths per

177 and additive and multiplicative comorbidity-hip fracture interactions.

178 Hip fracture is a potentially devastating condition for

179 ividuals, and to examine whether the risk of hip fracture is higher among HCV/HIV-coinfected persons,

180 Hip fracture leads to pain and immobilization with compl

181 Outcomes were hip fracture, major osteoporotic fracture, any fracture,

182 sed bisphosphonate use, and the incidence of hip fractures may be increasing.

183 Among 42230 patients with hip fracture (mean [SD] age, 80.1 years [10.7], 70.5% wo

184 dy cohort who underwent hemiarthroplasty for hip fracture (median age, 83 years; 8660 women [69.3%]),

185 ced clinical fractures (high SOE), including hip fractures (moderate SOE), but increased serious harm

186 Women with a previous hip fracture, more than one vertebral fracture, or a T-s

187 Patients aged 50 years or older treated for hip fracture (n = 245) were taken from Orthopedic wards

188 congestive heart failure (CHF) (n = 92,377), hip fracture (n = 90,046), or colon cancer (n = 26,195)

189 Background The overall rate of hip fractures not identified on radiographs but that req

190 More than 300,000 hip fractures occur each year in the United States.

191 Incident hip fractures occurring up to 10.7 y after baseline were

192 24 (3.5%) participants developed an incident hip fracture, of whom 413 (5.3%) died as a result.

193 older age and comorbidities associated with hip fracture on this increased perioperative risk is unk

194 f an adverse effect of high serum retinol on hip fracture or any interaction between retinol and 25-h

195 lculated 10-y probability of at least 3% for hip fracture or at least 20% for major osteoporotic frac

196 score of -2.5 or less, a history of spine or hip fracture, or a Fracture Risk Assessment Tool (FRAX)

197 t differences in risk of pulmonary embolism, hip fracture, or depression as a function of these three

198 ssociated with a significantly lower risk of hip fracture over a median of 1.32 years.

199 teoporotic fracture, as well as flavones for hip fracture (P < 0.05).

200 in the detection of radiographically occult hip fracture (P = .67), with a sensitivity of 79% and 87

201 10(-42), beta = -0.090) and confers risk of hip fracture (P = 1.0 x 10(-8), OR = 1.11).

202 umption, was associated with a lower risk of hip fractures, particularly with red wine consumption am

203 e previously observed excess mortality among hip fracture patients as compared with the general popul

204 phy scans of the femoral head extracted from hip fracture patients between the age of 70 and 93 years

205 The road to recovery for hip fracture patients is long and most patients may not

206 Hip fracture patients often have comorbid conditions.

207 Hip fracture patients showed elevated CSF lactate and py

208 Clinical trials in hip fracture patients with underlying cardiovascular dis

209 e attributed to the interaction and 6 to the hip fracture per se.

210 an BMD change was associated with 3.9 excess hip fractures per 100 persons.

211 Muscle attenuation alone provided effective hip fracture prediction.

212 However, its role in hip fracture prevention is not established and high cons

213 hip fracture, according to the FRAX 10-year hip fracture probability.

214 A higher hip fracture rate was observed with lower intakes of alp

215 As a result, decreases in hip fracture rates that followed the introduction of bis

216 Norway has the highest hip fracture rates worldwide and a relatively high vitam

217 It has been hypothesized that hip-fracture rates are higher in developed than in devel

218 indications in the trauma setting including hip fracture, reduction of joint dislocation, wound debr

219 rogram with minimal supervision after formal hip fracture rehabilitation ends has not been establishe

220 raphs but that require surgery (ie, surgical hip fractures) remains unclear in elderly patients who a

221 male) and 5002 patients undergoing emergency hip fracture repair (mean [SD] age, 79.5 [11.8] years; 1

222 to be discharged with post-acute care after hip fracture repair (odds ratio, 0.65; 95% CI, 0.47-0.89

223 ed worse postoperative outcomes after urgent hip fracture repair and not after elective colectomy.

224 my and 206,812 patients in 414 hospitals for hip fracture repair before matching.

225 Patients undergoing hip fracture repair from a multisite study in North Amer

226 ption that Medicare beneficiaries undergoing hip fracture repair in CAHs had a higher risk of in-hosp

227 s who underwent elective colectomy or urgent hip fracture repair in French hospitals between 2013 and

228 resection and patients undergoing emergency hip fracture repair successfully altered processes of ca

229 tomy, knee replacement, hip replacement, and hip fracture repair), mortality was equivalent between C

230 fe-saving procedures (eg, cancer surgery and hip fracture repair).

231 grafting, colectomy, total hip arthroplasty, hip fracture repair, and lumbar spine surgery.

232 After hip fracture repair, patients in hospitals with major de

233 resection and patients undergoing emergency hip fracture repair.

234 te end point of humerus, forearm, pelvis, or hip fracture requiring intervention.

235 stimate mechanical parameters that relate to hip fracture resistance by using MR images.

236 0.73 for any fragility fracture and 0.76 for hip fractures, respectively (P >= .73 compared with FRAX

237 Opioid use was associated with increased hip fracture risk (adjusted OR, 1.39; 95% CI, 1.26 to 1.

238 Alendronate and raloxifene have a similar hip fracture risk (hazard ratio [HR] 1.03, 95% confidenc

239 al prednisolone is associated with decreased hip fracture risk and adverse effects.

240 Reduced hip fracture risk in both men (n = 1958) and women (n =

241 t pain in patients with ESKD) contributes to hip fracture risk in patients with ESKD on hemodialysis

242 Despite opioids' known association with hip fracture risk in the general population, they are co

243 beverage most significantly associated with hip fracture risk was red wine (RR per serving = 0.59; 9

244 Long-term hormone therapy reduces hip fracture risks but has serious harms.

245 ted with a significant 14% increased risk of hip fracture (RR: 1.14; 95% CI: 1.06, 1.23).

246 itive scores, BMI, creatinine, arthritis and hip fracture, serum albumin and hemoglobin, and physical

247 Hip fracture served as a falsification outcome.

248 st that the treatment of older patients with hip fractures should be organised as orthogeriatric care

249 months) of intervention models consisting of hip fracture-specific care in conjunction with managemen

250 Following hip fracture surgery (n = 319,804), 10,931 patients (3.4

251 the optimal time window in which to conduct hip fracture surgery before the risk of complications in

252 rospective cohort study of adults undergoing hip fracture surgery between April 1, 2009, and March 31

253 In a large cohort of French patients, hip fracture surgery compared with elective THR was asso

254 Although wait times for hip fracture surgery have been linked to mortality and a

255 ), and insufficient evidence from 1 trial on hip fracture surgery suggested more surgical-site bleedi

256 trated a higher risk of mortality (1.82% for hip fracture surgery vs 0.31% for elective THR; absolute

257 major postoperative complications (5.88% for hip fracture surgery vs 2.34% for elective THR; absolute

258 es of patients who underwent elective THR or hip fracture surgery was created using a multivariable l

259 Among adults undergoing hip fracture surgery, increased wait time was associated

260 is associated with reduced ambulation after hip fracture surgery, whereas GNRI also contributes to i

261 0-2.62]; P < .001) among patients undergoing hip fracture surgery.

262 omorbidity compared with patients undergoing hip fracture surgery.

263 cated greater use of regional anesthesia for hip fracture surgery.

264 r rates of walking in a patient cohort after hip fracture surgery.

265 rtment visits for elders up to 2 years after hip-fracture surgery, above and beyond the effects of us

266 bin level was below 10 g per deciliter after hip-fracture surgery.

267 coronary artery disease, acute pancreatitis, hip fracture, syncope).

268 For hip fracture, the estimated mean difference in T score f

269 had completed standard rehabilitation after hip fracture, the use of a home-based functionally orien

270 ion of patients aged 70 years or more with a hip fracture to comprehensive geriatric care in a dedica

271 pulmonary disease) and a surgical diagnosis (hip fracture treated with arthroplasty) in 2010.

272 Among patients with hip fracture treated with hemiarthroplasty in a large US

273 Qualitative similarities between hip fracture trends in different countries suggests vari

274 RRs were computed for hip fracture using Cox proportional hazards models, adju

275 antify the burden of disease due to incident hip fracture using DALYs in prospective cohorts in the C

276 lity-adjusted life-years (DALYs) lost due to hip fractures using real-life follow-up cohort data.

277 no comorbidity, survival was reduced by 17% (hip fracture vs. no hip fracture).

278 requency of radiographically occult surgical hip fracture was 39% (1110 of 2835 patients; 95% confide

279 Hip fracture was adjudicated by a central review of radi

280 less than or equal to -2.5, 10-year risk for hip fracture was greater than 3% (World Health Organizat

281 7 patients [10.6%]; P=0.04), and the risk of hip fracture was lower by 38% (41 of 2046 patients [2.0%

282 ions of 25-hydroxyvitamin D and s-retinol on hip fracture was observed (P = 0.68).

283 The rate of surgical hip fracture was reported in each study in which MRI was

284 The association with hip fractures was also elevated with new, short-term use

285 Mr W, an older man who sustained a fall and hip fracture, we present evidence-based components of ca

286 The best predictors of hip fracture were entropy (P = .007; reproducibility coe

287 Incidence rates of hip fracture were lowest among uninfected persons (1.29

288 The associations between risk factors and hip fracture were similar in strength across BMI strata.

289 Adjusted odds ratios (ORs) of hip fractures were calculated using logistic regression

290 Hip fractures were confirmed by a medical record review;

291 During follow-up, 1226 hip fractures were identified in women and 490 in men.

292 After 3 years, 149 hip fractures were prevented and 2 bisphosphonate-associ

293 , medication use, and other risk factors for hip fractures were reported on biennial questionnaires.

294 Health, lifestyle information, and hip fractures were self-reported on biennial questionnai

295 100 g/L within 3 days of surgery to repair a hip fracture, were eligible for enrolment.

296 ues that may arise in the older patient with hip fracture, while delivering evidence-based care compo

297 ry outcome was the incidence of osteoporotic hip fracture, while secondary outcomes were vertebral fr

298 eep learning model identified and classified hip fractures with expert-level performance, at the very

299 id not have cataract surgery, adjusted OR of hip fracture within 1 year after cataract surgery was 0.

300 s who had cataract surgery had lower odds of hip fracture within 1 year after surgery compared with p